Dr. Padmanabh Chivukula is a distinguished scientist and executive who currently holds the positions of Chief Scientific Officer and Chief Operating Officer at Arcturus Therapeutics Holdings Inc. With a robust background in pharmaceutical sciences, Dr. Chivukula has been instrumental in steering the company towards innovative advancements in RNA medicine. He joined Arcturus in 2013, bringing with him a wealth of experience and a vision for leveraging RNA technology to address unmet medical needs. Prior to his tenure at Arcturus, Dr. Chivukula held significant roles at other leading biotech firms, including Merck and Sirna Therapeutics, where he honed his skills in drug development and delivery systems. His academic credentials are equally impressive, with a Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco. Throughout his career, Dr. Chivukula has been recognized for his contributions to the field, with numerous publications and patents to his name. His work has focused on the development of novel lipid nanoparticle delivery systems, which have been pivotal in advancing Arcturus' pipeline of RNA therapeutics. In his dual role at Arcturus, Dr. Chivukula oversees the scientific strategy and operational execution of the company's research and development initiatives. His leadership has been crucial in driving the company's efforts to develop mRNA and saRNA therapeutics for a range of diseases, including rare genetic disorders and infectious diseases. Under his guidance, Arcturus has made significant strides in clinical trials and partnerships, positioning the company as a leader in the RNA therapeutics space. Dr. Chivukula's dedication to scientific excellence and his strategic vision continue to propel Arcturus towards its goal of transforming patient care through cutting-edge RNA technology.